APA (7th ed.) Citation

Fabris, L., Frión-Herrera, Y., Venturin, C., Cadamuro, M., Gasparello, J., Radu, C. M., . . . Simioni, P. (2026). HEPATIC FIBROSIS-DRIVEN TISSUE FACTOR EXPRESSION BY MALIGNANT CHOLANGIOCYTES IS ASSOCIATED WITH CANCER-ASSOCIATED THROMBOSIS AND POOR SURVIVAL IN INTRAHEPATIC CHOLANGIOCARCINOMA. Bleeding, Thrombosis & Vascular Biology, 5, 178.

Chicago Style (17th ed.) Citation

Fabris, L., et al. "HEPATIC FIBROSIS-DRIVEN TISSUE FACTOR EXPRESSION BY MALIGNANT CHOLANGIOCYTES IS ASSOCIATED WITH CANCER-ASSOCIATED THROMBOSIS AND POOR SURVIVAL IN INTRAHEPATIC CHOLANGIOCARCINOMA." Bleeding, Thrombosis & Vascular Biology 5 (2026): 178.

MLA (9th ed.) Citation

Fabris, L., et al. "HEPATIC FIBROSIS-DRIVEN TISSUE FACTOR EXPRESSION BY MALIGNANT CHOLANGIOCYTES IS ASSOCIATED WITH CANCER-ASSOCIATED THROMBOSIS AND POOR SURVIVAL IN INTRAHEPATIC CHOLANGIOCARCINOMA." Bleeding, Thrombosis & Vascular Biology, vol. 5, 2026, p. 178.